Proteomics of Cerebrospinal Fluid for Biomarker Discovery in Multiple Sclerosis
2013 (English)In: Clinical Laboratory International (CLI), ISSN 1373-1580, Vol. 37, 29-31 p.Article in journal (Refereed) Published
The discovery of reliable biomarkers, which are eligible for the prediction of both disease progression and response to treatment, means a great challenge in the management of multiple sclerosis (MS), a devastating disease of the central nervous system. The results of recent proteomic findings from the cerebrospinal fluid of MS patients hold promise of finding ideal biomarkers in the near future.
Place, publisher, year, edition, pages
Brussels, Belgium: PanGlobal Media , 2013. Vol. 37, 29-31 p.
Medical and Health Sciences Chemical Sciences
IdentifiersURN: urn:nbn:se:uu:diva-203482OAI: oai:DiVA.org:uu-203482DiVA: diva2:636784